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increased rates of CAE following LMCA PCI.
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Background: Percutaneous coronary intervention (PCI) of complex true coronary
bifurcation lesions is challenging and whether to use a dedicated side branch stent is
still debatable. To date there is no published study evaluating the safety and efﬁcacy of
using an Everolimus-eluting stent (EES) in diabetic patients with true bifurcation
lesions treated with dedicated 2-stent (2S) vs. a provisional 1-stent (1S) technique. We
sought to compare outcomes with a dedicated 2S vs. provisional 1S strategy among
diabetic patients undergoing bifurcation stenting using EES.
Methods: We identiﬁed 202 diabetic patients with complex true bifurcation (Medina
classiﬁcation 1,1,1; 1,0,1; and 0,1,1) lesion who underwent bifurcation PCI using EES
from February 2010 to December 2011. The PCI strategy was either a provisional 1S
(n¼144) or dedicated 2S (n¼58) technique. Statistical analysis with all available
follow-up data were constructed for time-to-event variables with Kaplan-Meier
methodology and compared by log-rank test.
Results: The baseline characteristics were well matched between two PCI strategies.
In-hospital major adverse cardiac event (MACE) and postprocedure MI (CK-MB >3x
Normal, 8.33% vs. 10.34%, P¼0.65). At 1-year follow-up, MACE tended to be lower
for the 2S compared to the provisional 1S approach with the time to event analysis
depicted in Figure 1 (P¼0.08).JACC Vol 62/18/Suppl B j October 27–November 1, 2013 j TCT AbstrConclusions: The conservative provisional 1S technique tended to have greater
MACE events compared to the dedicated 2S technique in diabetic patients after
treatment of complex true bifurcation lesions using newer generation EES.
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Background: Main vessel stenting with ﬁnal kissing balloon dilatation
(FKBD) is widely employed, but many technical variations are possible that
may affect the ﬁnal result. In this study, two different FKBD strategies were
investigated.
Methods: Finite element simulations were used to virtually deploy and post-dilate
three stent platforms within three bifurcation models, mimicking a range of
coronary bifurcation anatomies. Stents were sized according to the distal branch
diameter and deployed to a diameter of 3.2mm following the compliance charts.
During a second step, a shorter (but larger) balloon was used to post-dilate the
proximal stent segment. Two FKBD strategies were evaluated: “simultaneous
FKBD” (n¼27) and “modiﬁed FKBD” (n¼27). In the simultaneous FKBD, both
the side and main branch balloon were simultaneously inﬂated and deﬂated, with
a maximal balloon pressure of 12atm. In the modiﬁed FKBD, the side branch
balloon was inﬂated to a pressure of 12atm, and then deﬂated to 4atm. Subse-
quently, the main branch balloon was inﬂated to a pressure of 12atm. Eventually,
both balloons were fully deﬂated. The following quantitative measures were used
to compare both FKBD strategies: percentage of side branch obstruction, ellip-
ticity index (the ratio of the maximal to the minimal diameter in the proximal
stent segment) and percentage of malapposed struts (deﬁned as strut-artery
distance of more than 100 micron). The accuracy of the computer simulation
results was evaluated by comparing the virtually predicted stent deformations
with stent deformations observed during microCT visualised in-vitro bench
testing.
Results: Modiﬁed FKBD results in a lower ostial stenosis as compared to simulta-
neous FKBD (159% vs. 2011%, p<0.001) and also reduces the elliptical stent
deformation (ellipticity index ¼ 1.170.05 vs. 1.360.06, p<0.001). The amount of
malapposed stent struts was not inﬂuenced by the FKBD technique (modiﬁed FKBD:
6.33.6%, simultaneous FKBD: 6.43.4%, p¼0.212).
Conclusions: The modiﬁed FKBD procedure reduces the elliptical stent deformation
and optimises the side branch access while avoiding stent distortion within the main
vessel.
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Background: Scant data exist regarding the impact of diabetes mellitus (DM) status
on percutaneous coronary intervention (PCI) for left main (LM) coronary artery
disease. We sought to compare the impact of the presence of DM at baseline among
pts undergoing LM PCI on long-term ischemic outcomes.
Methods: Data from all consecutive patients from a single center were prospec-
tively collected. Pts were stratiﬁed according to the presence or absence of DM at
baseline. Coronary angiograms were analyzed by an independent angiographic
core laboratory and all events adjudicated by an independent clinical events
committee. Adverse ischemic outcomes were compared between the 2 groups up
to 6-year follow-up.
Results: Between Jan 2004 and Dec 2010, 1,528 consecutive pts underwent LM
PCI. DM was present in 369 (24.1%) pts. Pts with DM were more likely to have
increased weight, prior MI, hypertension, dyslipidemia and prior stroke. Angio-
graphically, DM pts presented more frequently with 3-vessel-disease, 1,1,1 medina
bifurcation and higher baseline SYNTAX score. Despite having more lesions treated
and more stents implanted, DM pts had higher residual SYNTAX score after
revascularization. One-year dual antiplatelet therapy compliance rates were high
among the complete cohort (95.3%) and similar between both groups. At 6-year
follow-up, no differences were seen in rates of all-cause death (6.0% vs. 4.7%,
p¼0.36) and deﬁnite/probable stent thrombosis (ST; 1.6% vs. 1.7%, p¼0.90)
between groups. However, DM pts had a higher rate of target lesion revasculari-
zation (TLR; 8.4% vs. 4.4%, p¼0.005), target vessel revascularization (TVR; 13.6%
vs. 8.1%, p¼0.003), and stroke (4.9% vs. 1.3%; p¼0.002). By multivariate analysis,acts/POSTER/Bifurcation and Left Main Interventions B129
